These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15366109)

  • 21. GlaxoSmithKline, under pressure, cuts price of AIDS treatment for poor countries.
    Fleck F
    Bull World Health Organ; 2003; 81(6):469. PubMed ID: 12894339
    [No Abstract]   [Full Text] [Related]  

  • 22. Activists drive access to treatment campaign at conference.
    Zipperer M
    Bull World Health Organ; 2004 Sep; 82(9):713. PubMed ID: 15628211
    [No Abstract]   [Full Text] [Related]  

  • 23. World CAB meets with Gilead.
    Huff B
    GMHC Treat Issues; 2006; 20(4-7):6-8. PubMed ID: 17228449
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug pricing. AHF to file suit against Glaxo for African AIDS-related deaths.
    AIDS Policy Law; 2003 Dec; 18(22):5. PubMed ID: 14974398
    [No Abstract]   [Full Text] [Related]  

  • 25. Incremental drug treatment cost in HIV-positive patients in industry-sponsored clinical trials.
    Perrín RS; López FJ
    Ann Pharmacother; 2008 Nov; 42(11):1586-91. PubMed ID: 18780807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Key Opinion Leaders - SMi's Second Conference Knowledge Leaders.
    Mason VL
    IDrugs; 2009 Dec; 12(12):770-3. PubMed ID: 19943219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gilead's deal of a lifetime.
    Huggett B; Scott C
    Nat Biotechnol; 2009 May; 27(5):423. PubMed ID: 19430443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trip into the unknown.
    Anderson T
    Nature; 2007 Nov; 450(7169):471. PubMed ID: 18033269
    [No Abstract]   [Full Text] [Related]  

  • 29. Biotech jostles with pharma for slice of HIV market.
    Katsnelson A
    Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375
    [No Abstract]   [Full Text] [Related]  

  • 30. AIDS advocates returning to their activism roots. Protesters welcome arrests and publicity.
    AIDS Alert; 2004 Aug; 19(8):90-3. PubMed ID: 15300946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Funding alert: wake up and support WORLD.
    James JS
    AIDS Treat News; 2003 May; (391):6-7. PubMed ID: 12866498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activist initiative.
    Vazquez E
    Posit Aware; 1999; 10(4):25. PubMed ID: 11366801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Balancing pills and patents: intellectual property and the HIV/AIDS crisis.
    Nderitu T
    E Law; 2001 Sep; 8(3):E5. PubMed ID: 16903022
    [No Abstract]   [Full Text] [Related]  

  • 34. More interest in AIDS drug access plan.
    Nature; 2001 Jun; 411(6841):984. PubMed ID: 11447609
    [No Abstract]   [Full Text] [Related]  

  • 35. Groundswell.
    Karch G
    GMHC Treat Issues; 2003 Dec; 17(12):12. PubMed ID: 15011649
    [No Abstract]   [Full Text] [Related]  

  • 36. An unequal activism for an unequal epidemic?
    Selemogo M
    Dev World Bioeth; 2005 May; 5(2):153-68. PubMed ID: 15842724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Italian drug firms rethink ban on conference support.
    Feder T
    Nature; 1994 Dec; 372(6505):392. PubMed ID: 7984223
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmaceutical reference pricing in Germany: definition of therapeutic groups, price setting through regression procedure and effects].
    Stargardt T; Schreyögg J; Busse R
    Gesundheitswesen; 2005 Jul; 67(7):468-77. PubMed ID: 16103970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anatomy of a successful campaign to lower AIDS drug prices.
    AIDS Policy Law; 2003 May; 18(10):7. PubMed ID: 12809098
    [No Abstract]   [Full Text] [Related]  

  • 40. AchemAsia 2007 announcement: China's biotechnology industry on the upswing.
    Biotechnol J; 2007 Mar; 2(3):288-90. PubMed ID: 17354215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.